Prenetics Global Ltd
PRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001876431
In the last 90 days, Prenetics Global Ltd insiders filed 2 open-market purchases and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.
Other share classesPRENW
13F holders, Q2 2023
Institutional positions in Prenetics Global Ltd as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +6 vs. Q1 2023
- Shares held
- 16.6M
- +10.8M (+186.8%) vs. Q1 2023
- Total value
- $14.7M
- +$9.20M (+165.9%) vs. Q1 2023
- New holders
- 7
- 1 more added
- Sold out
- 1
- 2 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $23.3M |
| Q1 2026 | 34 | $38.5M |
| Q4 2025 | 33 | $27.4M |
| Q3 2025 | 16 | $17.2M |
| Q2 2025 | 11 | $9.78M |
| Q1 2025 | 9 | $4.57M |
| Q4 2024 | 9 | $6.60M |
| Q3 2024 | 8 | $4.47M |
| Q2 2024 | 7 | $7.06M |
| Q1 2024 | 9 | $60.5M |
| Q4 2023 | 6 | $7.27M |
| Q3 2023 | 15 | $7.69M |
| Q2 2023 | 20 | $14.7M |
| Q1 2023 | 14 | $5.55M |
| Q4 2022 | 12 | $12.1M |
| Q3 2022 | 10 | $21.6M |
| Q2 2022 | 11 | $23.9M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Prenetics Global Ltd; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Aspire Private Capital, LLC | 200 | $178 | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 226 | $201 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 408 | $363 | 0.00% | +408 | New |
| Bank of America Corp | 1,654 | $1.47K | 0.00% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 11,732 | $10.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 17,382 | $15.5K | 0.00% | +17,382 | New |
| HCR Wealth Advisors | 20,000 | $17.8K | 0.00% | +20,000 | New |
| Fan Yu | 25,000 | $24.0K | 1.88% | 00.0% | Unchanged |
| Gladius Capital Management LP | 29,594 | $26.3K | 0.01% | +29,594 | New |
| Quinn Opportunity Partners LLC | 35,099 | $31.2K | 0.00% | −10.0% | Reduced |
| Geode Capital Management, LLC | 44,743 | $39.8K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 48,278 | $43.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 55,800 | $50.0K | 0.00% | +25,000+81.2% | Added |
| Millennium Management LLC | 59,195 | $52.7K | 0.00% | −71,246−54.6% | Reduced |
| Brown Advisory Inc | 71,771 | $63.9K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 80,675 | $71.8K | 0.00% | +80,675 | New |
| Dantai Capital Ltd | 104,437 | $92.9K | 0.15% | +104,437 | New |
| Dymon Asia Capital (Singapore) Pte. Ltd. | 150,687 | $134.1K | 0.19% | 00.0% | Unchanged |
| Aspex Management (HK) Ltd | 5,192,250 | $4.62M | 0.13% | 00.0% | Unchanged |
| Prudential PLC | 10,621,132 | $9.45M | 0.11% | +10,621,132 | New |
| ARS Investment Partners, LLC | 0 | $0 | 0.00% | −35,500−100.0% | Sold out |